GeneTether Therapeutics Inc

GeneTether Therapeutics Inc. (GNTTF) is a biotechnology firm dedicated to advancing genetic medicines. Its primary focus involves pioneering highly efficient and precise gene-editing solutions designed for human therapeutic applications. The company achieves this by developing innovative gene-editing therapies built upon its unique and proprietary GeneTether platform. Furthermore, GeneTether is strategically establishing a robust discovery pipeline, aiming to uncover treatments for rare, single-gene disorders that affect both the kidneys and the skin. A key strength of their GeneTether platform is its capacity to significantly boost the effectiveness of existing genome editing technologies, including well-known tools such as CRISPR-Cas, TALENs, and ZFNs.